Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
Sign Up to like & getrecommendations! Published in 2021 at "Neurological Sciences"
DOI: 10.1007/s10072-021-05397-7
Abstract: Several concerns regard the immunogenicity of SARS-CoV-2 vaccines in people with multiple sclerosis (pwMS), since the majority of them is treated with immunomodulating/immunosuppressive disease modifying therapies. Here we report the first data on the humoral… read more here.
Keywords: response; vaccine; multiple sclerosis; sars cov ... See more keywords
Dynamics of humoral response in naturally-infected cattle after vaccination against leptospirosis.
Sign Up to like & getrecommendations! Published in 2018 at "Acta tropica"
DOI: 10.1016/j.actatropica.2018.07.014
Abstract: Vaccination is one of the most important measures for the control of bovine leptospirosis. Despite the broad usage of vaccination against leptospirosis in cattle worldwide, the dynamics of the post-vaccine immune response remain controversial and… read more here.
Keywords: vaccination leptospirosis; leptospirosis; naturally infected; vaccination ... See more keywords
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1
Sign Up to like & getrecommendations! Published in 2021 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2021.06.227
Abstract: Background and Aims: Unravelling autoimmune targets triggered by SARS-CoV-2 infection may provide crucial insights in the physiopathology of the disease and foster the development of potential therapeutic candidate targets and prognostic tools. We want to… read more here.
Keywords: anti apoa; trigger humoral; response apolipoprotein; sars cov ... See more keywords
Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies
Sign Up to like & getrecommendations! Published in 2021 at "Multiple Sclerosis and Related Disorders"
DOI: 10.1016/j.msard.2021.103150
Abstract: Background It has been generally accepted that people with MS (PwMS) should be vaccinated against COVID-19. The aim of our investigation was to evaluate the humoral response to natural SARS-CoV-2 infection and to two COVID-19… read more here.
Keywords: covid vaccines; response; reconstitution therapies; sars cov ... See more keywords
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients
Sign Up to like & getrecommendations! Published in 2022 at "Transplantation Proceedings"
DOI: 10.1016/j.transproceed.2022.02.011
Abstract: Background: The majority of solid organ transplant recipients did not develop an appreciable serologic response following two doses of mRNA SARS-CoV-2 vaccine. Methods: We analyzed the humoral response following third dose of BNT162b2 vaccine in… read more here.
Keywords: response; humoral response; transplant recipients; kidney ... See more keywords
The kinetics of humoral response and its relationship with the disease severity in COVID-19
Sign Up to like & getrecommendations! Published in 2020 at "Communications Biology"
DOI: 10.1038/s42003-020-01526-8
Abstract: Coronavirus Disease 2019 (COVID-19) has caused a global pandemic. Here we profiled the humoral response against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by measuring immunoglobulin (Ig) A, IgM, and IgG against nucleocapsid and spike… read more here.
Keywords: disease severity; antibody; humoral response; disease ... See more keywords
Delayed Humoral Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Kidney Transplant Cohort
Sign Up to like & getrecommendations! Published in 2021 at "Transplantation"
DOI: 10.1097/tp.0000000000003952
Abstract: W previously published disappointing results regarding the humoral response 28 d after the second dose of the BNT162b2 (Pfizer) vaccine in kidney transplant recipients (KTRs). The present article reports the serological response rate 90 d… read more here.
Keywords: response; delayed humoral; cohort; day ... See more keywords
Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant Recipients
Sign Up to like & getrecommendations! Published in 2022 at "Transplantation"
DOI: 10.1097/tp.0000000000004383
Abstract: Background. The effectiveness of the fourth BNT162b2 vaccination in reducing the rate and severity of coronavirus disease 2019 (COVID-19) caused by the Omicron variant in renal transplant recipients (RTRs) is unknown. Methods. Interviews were conducted… read more here.
Keywords: omicron; fourth dose; disease; severity ... See more keywords
Humoral response and safety of the BNT162b2 and mRNA‐1273 COVID‐19 vaccines in patients with haematological diseases treated with anti‐CD20 antibodies: An observational study
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18151
Abstract: In clinical trials, vaccines against study to assess the effectiveness and safety of COVID- 19 mRNA vaccines in end- the proportion of receptor- binding the S1 subunit SARS- CoV- 2 spike protein evaluated humoral responses… read more here.
Keywords: safety; mrna; covid; response safety ... See more keywords
BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathy
Sign Up to like & getrecommendations! Published in 2023 at "Transplant Infectious Disease"
DOI: 10.1111/tid.14012
Abstract: Among kidney transplant recipients (KTR) with BK virus associated nephropathy (BKVN), BKV genotypes’ evolution and anti‐BKV humoral response are not well established. We aim to analyze BKV replication and genetic evolution following transplantation, and characterize… read more here.
Keywords: associated nephropathy; kidney transplant; humoral response; transplant recipients ... See more keywords
Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE)
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2022-222498
Abstract: Severe COVID19 is associated with a poor prognosis among patients with systemic lupus erythematosus (SLE). Accordingly, patients with SLE receiving immunosuppressive drugs have been prioritised for vaccination in France. However, patients with autoimmune diseases—especially those… read more here.
Keywords: patients sle; omicron; two doses; humoral response ... See more keywords